These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 28189428)

  • 1. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
    Gandaglia G; Briganti A; Clarke N; Karnes RJ; Graefen M; Ost P; Zietman AL; Roach M
    Eur Urol; 2017 Nov; 72(5):689-709. PubMed ID: 28189428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer.
    Gandaglia G; Cozzarini C; Mottrie A; Bossi A; Fossati N; Montorsi F; Briganti A
    Curr Oncol Rep; 2015 Dec; 17(12):53. PubMed ID: 26449841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
    Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-prostatectomy radiation therapy for locally recurrent prostate cancer.
    Isharwal S; Stephenson AJ
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1003-1012. PubMed ID: 28922958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
    Briganti A; Wiegel T; Joniau S; Cozzarini C; Bianchi M; Sun M; Tombal B; Haustermans K; Budiharto T; Hinkelbein W; Di Muzio N; Karakiewicz PI; Montorsi F; Van Poppel H
    Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
    Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
    BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early salvage radiation therapy post-prostatectomy: key considerations.
    Morlacco A; Karnes RJ
    Future Oncol; 2016 Nov; 12(22):2579-2587. PubMed ID: 27387852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant and salvage radiotherapy after radical prostatectomy.
    Höcht S; Wiegel T; Schostak M; Hinkelbein W
    Onkologie; 2002 Jun; 25(3):201-6. PubMed ID: 12119453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer: immediate postoperative or salvage?].
    Pasquier D; Kouto H; Ballereau C
    Prog Urol; 2009 Jul; 19(7):447-56. PubMed ID: 19559374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy.
    Stephenson AJ; Bolla M; Briganti A; Cozzarini C; Moul JW; Roach M; van Poppel H; Zietman A
    Eur Urol; 2012 Mar; 61(3):443-51. PubMed ID: 22036777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy following radical prostatectomy for prostate cancer.
    Daly T; Hickey BE; Lehman M; Francis DP; See AM
    Cochrane Database Syst Rev; 2011 Dec; (12):CD007234. PubMed ID: 22161411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
    Thompson IM; Valicenti RK; Albertsen P; Davis BJ; Goldenberg SL; Hahn C; Klein E; Michalski J; Roach M; Sartor O; Wolf JS; Faraday MM
    J Urol; 2013 Aug; 190(2):441-9. PubMed ID: 23707439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
    Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
    BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review.
    Pasquier D; Ballereau C
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):972-9. PubMed ID: 18954710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).
    Parker CC; Petersen PM; Cook AD; Clarke NW; Catton C; Cross WR; Kynaston H; Parulekar WR; Persad RA; Saad F; Bower L; Durkan GC; Logue J; Maniatis C; Noor D; Payne H; Anderson J; Bahl AK; Bashir F; Bottomley DM; Brasso K; Capaldi L; Chung C; Cooke PW; Donohue JF; Eddy B; Heath CM; Henderson A; Henry A; Jaganathan R; Jakobsen H; James ND; Joseph J; Lees K; Lester J; Lindberg H; Makar A; Morris SL; Oommen N; Ostler P; Owen L; Patel P; Pope A; Popert R; Raman R; Ramani V; Røder A; Sayers I; Simms M; Srinivasan V; Sundaram S; Tarver KL; Tran A; Wells P; Wilson J; Zarkar AM; Parmar MKB; Sydes MR;
    Ann Oncol; 2024 Jul; 35(7):656-666. PubMed ID: 38583574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant and salvage radiotherapy for prostate cancer: impact on freedom from biochemical relapse and survival.
    Pacholke HD; Wajsman Z; Algood CB; Neulander EZ; Morris CG; Zlotecki RA
    Urology; 2004 Nov; 64(5):982-6. PubMed ID: 15533490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis.
    Tao R; Dai J; Bai Y; Yang J; Sun G; Zhang X; Zhao J; Zeng H; Shen P
    Radiat Oncol; 2019 Nov; 14(1):197. PubMed ID: 31706339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postoperative radiotherapy for prostate cancer: when to propose it? What is the place for androgen deprivation?].
    Benziane-Ouaritini N; Sargos P; Beauval JB; Supiot S; Latorzeff I
    Cancer Radiother; 2021 Oct; 25(6-7):667-673. PubMed ID: 34391651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study.
    Mizowaki T; Aoki M; Nakamura K; Yorozu A; Kokubo M; Karasawa K; Kozuka T; Nakajima N; Sasai K; Akimoto T
    J Radiat Res; 2015 Jul; 56(4):750-6. PubMed ID: 25910489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.